Chengdu Jinruijiye Biotechnology

Chengdu Jinruijiye Biotechnology is a high-tech biopharmaceutical enterprise based in Chengdu, China, dedicated to the development of innovative biological products and medical devices. The company is a leader in the field of recombinant humanized collagen, specifically Type III collagen, utilizing a proprietary yeast expression system to produce high-purity, non-immunogenic proteins. These products are primarily applied in medical aesthetics, wound repair, and gynecological treatments. Beyond its collagen platform, Jinruijiye is advancing a pipeline of small molecule inhibitors targeting oncology and metabolic disorders. The company operates integrated R&D and GMP-certified manufacturing facilities to support its transition from laboratory discovery to commercial production. Its flagship products have received regulatory approvals in China, positioning the company as a key player in the regenerative medicine sector.